✦ LIBER ✦

A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones

✍ Scribed by Mary-Ellen Taplin; Judith Manola; William K. Oh; Philip W. Kantoff; Glenn J. Bubley; Matthew Smith; Diana Barb; Christos Mantzoros; Edward P. Gelmann; Steven P. Balk

Book ID: 109053891
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 132 KB
Volume: 101
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2008.07509.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of oral panobinostat alo

A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer

✍ Dana Rathkopf; Bryan Y. Wong; Robert W. Ross; Aseem Anand; Erika Tanaka; Margare 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 378 KB

A phase II study of fenretinide in patie

A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research Group

✍ M. M. Moore; M. Stockler; R. Lim; T. S. K. Mok; M. Millward; M. J. Boyer 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 228 KB

Open-label, phase I dose-escalation stud

Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer

✍ Corcoran, N M; Hovens, C M; Michael, M; Rosenthal, M A; Costello, A J 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 333 KB

A phase II study of the antisense oligon

A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancer

✍ Srikala S. Sridhar; Christina M. Canil; Kim N. Chi; Sebastien J. Hotte; Scott Er 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 298 KB

Diethylstilbestrol and docetaxel : A pha

Diethylstilbestrol and docetaxel : A phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer

✍ R. Bruce Montgomery; Peter S. Nelson; Daniel Lin; Christopher W. Ryan; Mark Garz 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Abstract ## BACKGROUND. The addition of diethylstilbestrol to docetaxel modified tubulin composition and improved the response of prostate cancer to chemotherapy in preclinical models. An attempt was made to recapitulate the observations in a clinical trial. ## METHODS. Twenty‐nine patients w

Long-term outcome of a phase II study of

Long-term outcome of a phase II study of weekly docetaxel with a short course of estramustine and enoxaparine in hormone-resistant prostate cancer patients

✍ A. González-Martín; E. Fernández; M. A. Vaz; J. Burgos; M. López García; R. Rodr 📂 Article 📅 2007 🏛 Springer Milan 🌐 Spanish ⚖ 92 KB